Concepedia

Hari Sankaran

HS

8

Publications

186

Citations

8

H-Index

2019

Active since

Affiliations

Tata Memorial Hospital(Current)

National Cancer Institute

Homi Bhabha National Institute

Frederick National Laboratory for Cancer Research

National Institutes of Health

Hari Sankaran is an author at Tata Memorial Hospital specializing in neuropathology, antifibrotic therapy, and neurology.

ORCID

Top concepts

Publications per year

2019–2025

8

Publications

8

Holistic support coupled with prospective tracking reduces abandonment in childhood cancers: A report from India

Shalini Jatia, Maya Prasad, Amey Paradkar et al. · Pediatric Blood & Cancer · 2019 · 38 citations · Full text

A comparison of asparaginase activity in generic formulations of <i>E.coli</i> derived L‐ asparaginase: In‐vitro study and retrospective analysis of asparaginase monitoring in pediatric patients with leukemia

Hari Sankaran, Soumika Sengupta, Vaitashi Purohit et al. · British Journal of Clinical Pharmacology · 2020 · 37 citations · Full text

Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial

Andrea M. Gross, Geraldine O’Sullivan Coyne, Eva Dombi et al. · Nature Medicine · 2025 · 27 citations · Full text

, , +6

Molecular genomic features associated with <i>in vitro</i> response of the NCI‐60 cancer cell line panel to natural products

Julia Krushkal, Simarjeet Negi, Laura M. Yee et al. · Molecular Oncology · 2020 · 21 citations · Full text

Increased toxicities in children with Burkitt lymphoma treated with rituximab: Experience from a tertiary cancer center in India

Shyam Srinivasan, Nirmalya Roy Moulik, Anand KC et al. · Pediatric Blood & Cancer · 2020 · 17 citations

Rows per page

1–5 of 8